Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19

NCT04261517 is registered in ClinicalTrials.gov with Shanghai Public Health Clinical Center as lead sponsor.

NCT NCT04261517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04261517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19
Lead sponsor
Shanghai Public Health Clinical Center
Phase
Phase 3
Overall status
Completed
Start date
February 6, 2020
Completion date
February 25, 2020
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus, covid-19, pneumonia, pneumocystis